P. Somaiya

发表

Vaccination with DC/tumor fusion cells results in cellular and humoral anti-tumor immune responses in patients with multiple myeloma DC/myeloma fusion vaccine induces immune responses

N. Munshi, P. Richardson, D. Kufe, 2017 .

Title: Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

N. Munshi, J. Laubach, P. Richardson, 2013 .

Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

Nikhil C. Munshi, Edie Weller, Kenneth Anderson, 2013, Clinical Cancer Research.

Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.

N. Munshi, P. Richardson, D. Kufe, 2011, Blood.

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.

P. Pandolfi, D. Kufe, R. Joyce, 2017, Blood.

DC/Aml Fusion Cell Vaccination Administered to AML Patients Who Achieve a Complete Remission Potently Expands Leukemia Reactive T Cells and Is Associated with Durable Remissions

D. Neuberg, D. Kufe, D. DeAngelo, 2015 .

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination In AML Patients

D. Neuberg, D. Kufe, D. DeAngelo, 2013 .

MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs

F. Slack, D. Kufe, E. Anastasiadou, 2016 .

Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation

N. Munshi, J. Laubach, P. Richardson, 2012 .